Extent of Cross-Resistance between Agents Used To Treat Human Immunodeficiency Virus Type 1 Infection in Clinically Derived Isolates

di Harrigan, P. Richard, Larder, Brendan A.
Pubblicazione 2002

Relative Replicative Fitness of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Isolates In Vitro

di Harrigan, P. Richard, Bloor, Stuart, Larder, Brendan A.
Pubblicazione 1998

Human Immunodeficiency Virus Type 1 Protease Cleavage Site Mutations Associated with Protease Inhibitor Cross-Resistance Selected by Indinavir, Ritonavir, and/or Saquinavir

di Côté, Hélène C. F., Brumme, Zabrina L., Harrigan, P. Richard
Pubblicazione 2001

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

di McGovern, Rachel A., Harrigan, P. Richard, Swenson, Luke C.
Pubblicazione 2010

Competitive Fitness Assays Indicate that the E138A Substitution in HIV-1 Reverse Transcriptase Decreases In Vitro Susceptibility to Emtricitabine

di Sluis-Cremer, Nicolas, Huber, Kelly D., Brumme, Chanson J., Harrigan, P. Richard
Pubblicazione 2014

Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients

di Ryscavage, Patrick, Kelly, Sean, Li, Jonathan Z., Harrigan, P. Richard, Taiwo, Babafemi
Pubblicazione 2014

The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus

di Jones, Bradley R, Howe, Anita Y M, Harrigan, P Richard, Joy, Jeffrey B
Pubblicato in Virus Evol (2018)

Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance

di Noguera-Julian, Marc, Edgil, Dianna, Harrigan, P Richard, Sandstrom, Paul, Godfrey, Catherine, Paredes, Roger
Pubblicato in J Infect Dis (2017)

Association Between HIV-1 RNA Level and CD4 Cell Count Among Untreated HIV-Infected Individuals

di Lima, Viviane D., Fink, Valeria, Yip, Benita, Hogg, Robert S., Harrigan, P. Richard, Montaner, Julio S. G.
Pubblicazione 2009

The Evolutionary Analysis of Emerging Low Frequency HIV-1 CXCR4 Using Variants through Time—An Ultra-Deep Approach

di Archer, John, Rambaut, Andrew, Taillon, Bruce E., Harrigan, P. Richard, Lewis, Marilyn, Robertson, David L.
Pubblicazione 2010

Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB

di Dahabieh, Matthew S, Ooms, Marcel, Brumme, Chanson, Taylor, Jeremy, Harrigan, P Richard, Simon, Viviana, Sadowski, Ivan
Pubblicazione 2014

Implementation of Next-Generation Sequencing for Hepatitis B Virus Resistance Testing and Genotyping in a Clinical Microbiology Laboratory

di Lowe, Christopher F., Merrick, Linda, Harrigan, P. Richard, Mazzulli, Tony, Sherlock, Christopher H., Ritchie, Gordon
Pubblicato in J Clin Microbiol (2016)

Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification

di Lima, Viviane D., Wang, Lu, Brumme, Chanson, Wu, Lang, Montaner, Julio S. G., Harrigan, P. Richard
Pubblicato in PLoS One (2017)

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study

di Harris, Marianne, Ganase, Bruce, Watson, Birgit, Harrigan, P. Richard, Montaner, Julio S. G., Hull, Mark W.
Pubblicato in AIDS Res Ther (2017)

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework

di Capina, Rupert, Li, Katherine, Kearney, Levon, Vandamme, Anne-Mieke, Harrigan, P. Richard, Van Laethem, Kristel
Pubblicato in Viruses (2020)

A Novel Polymorphism at Codon 333 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Can Facilitate Dual Resistance to Zidovudine and l-2′,3′-Dideoxy-3′-Thiacytidine...

di Kemp, Sharon D., Shi, Chaofu, Bloor, Stuart, Harrigan, P. Richard, Mellors, John W., Larder, Brendan A.
Pubblicazione 1998

Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Preventio...

di Milloy, M.-J., Wood, Evan, Kerr, Thomas, Hogg, Bob, Guillemi, Silvia, Harrigan, P. Richard, Montaner, Julio
Pubblicato in Clin Infect Dis (2016)

Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for fir...

di Lima, Viviane D, Hull, Mark, McVea, David, Chau, William, Harrigan, P Richard, Montaner, Julio SG
Pubblicato in J Int AIDS Soc (2016)

Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury

di Davani, Ehsan Y, Brumme, Zabrina, Singhera, Gurpreet K, Côté, Hélène CF, Harrigan, P Richard, Dorscheid, Delbert R
Pubblicazione 2003

Determining Human Immunodeficiency Virus Coreceptor Use in a Clinical Setting: Degree of Correlation between Two Phenotypic Assays and a Bioinformatic Model

di Skrabal, Katharina, Low, Andrew J., Dong, Winnie, Sing, Tobias, Cheung, Peter K., Mammano, Fabrizio, Harrigan, P. Richard
Pubblicazione 2007